Pharmaceuticals and Biotechnology R D and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pharmaceuticals and Biotechnology R & D Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceuticals and Biotechnology R & D Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceuticals and Biotechnology R & D Overall Market Size
2.1 Global Pharmaceuticals and Biotechnology R & D Market Size: 2022 VS 2029
2.2 Global Pharmaceuticals and Biotechnology R & D Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceuticals and Biotechnology R & D Players in Global Market
3.2 Top Global Pharmaceuticals and Biotechnology R & D Companies Ranked by Revenue
3.3 Global Pharmaceuticals and Biotechnology R & D Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceuticals and Biotechnology R & D Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmaceuticals and Biotechnology R & D Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R & D Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceuticals and Biotechnology R & D Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R & D Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmaceuticals and Biotechnology R & D Market Size Markets, 2022 & 2029
4.1.2 Drug
4.1.3 Medical Equipment
4.1.4 Vaccine
4.1.5 Others
4.2 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue & Forecasts
4.2.1 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2023
4.2.2 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue, 2024-2029
4.2.3 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceuticals and Biotechnology R & D Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Homecare
5.1.5 Others
5.2 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue & Forecasts
5.2.1 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2023
5.2.2 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue, 2024-2029
5.2.3 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pharmaceuticals and Biotechnology R & D Market Size, 2022 & 2029
6.2 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue & Forecasts
6.2.1 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2023
6.2.2 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue, 2024-2029
6.2.3 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.3.2 US Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.3.3 Canada Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.3.4 Mexico Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.4.2 Germany Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.3 France Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.4 U.K. Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.5 Italy Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.6 Russia Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.7 Nordic Countries Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.8 Benelux Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.5.2 China Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.3 Japan Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.4 South Korea Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.5 Southeast Asia Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.6 India Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.6.2 Brazil Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.6.3 Argentina Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.7.2 Turkey Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7.3 Israel Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7.4 Saudi Arabia Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7.5 UAE Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
7 Pharmaceuticals and Biotechnology R & D Companies Profiles
7.1 ROCHE
7.1.1 ROCHE Company Summary
7.1.2 ROCHE Business Overview
7.1.3 ROCHE Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.1.4 ROCHE Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.1.5 ROCHE Key News & Latest Developments
7.2 JOHNSON & JOHNSON
7.2.1 JOHNSON & JOHNSON Company Summary
7.2.2 JOHNSON & JOHNSON Business Overview
7.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.2.4 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.2.5 JOHNSON & JOHNSON Key News & Latest Developments
7.3 MERCK
7.3.1 MERCK Company Summary
7.3.2 MERCK Business Overview
7.3.3 MERCK Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.3.4 MERCK Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.3.5 MERCK Key News & Latest Developments
7.4 NOVARTIS
7.4.1 NOVARTIS Company Summary
7.4.2 NOVARTIS Business Overview
7.4.3 NOVARTIS Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.4.4 NOVARTIS Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.4.5 NOVARTIS Key News & Latest Developments
7.5 PFIZER
7.5.1 PFIZER Company Summary
7.5.2 PFIZER Business Overview
7.5.3 PFIZER Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.5.4 PFIZER Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.5.5 PFIZER Key News & Latest Developments
7.6 SANOFI
7.6.1 SANOFI Company Summary
7.6.2 SANOFI Business Overview
7.6.3 SANOFI Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.6.4 SANOFI Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.6.5 SANOFI Key News & Latest Developments
7.7 BAYER
7.7.1 BAYER Company Summary
7.7.2 BAYER Business Overview
7.7.3 BAYER Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.7.4 BAYER Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.7.5 BAYER Key News & Latest Developments
7.8 BRISTOL-MYERS SQUIBB
7.8.1 BRISTOL-MYERS SQUIBB Company Summary
7.8.2 BRISTOL-MYERS SQUIBB Business Overview
7.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.8.4 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.8.5 BRISTOL-MYERS SQUIBB Key News & Latest Developments
7.9 ASTRAZENECA
7.9.1 ASTRAZENECA Company Summary
7.9.2 ASTRAZENECA Business Overview
7.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.9.4 ASTRAZENECA Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.9.5 ASTRAZENECA Key News & Latest Developments
7.10 GLAXOSMITHKLINE
7.10.1 GLAXOSMITHKLINE Company Summary
7.10.2 GLAXOSMITHKLINE Business Overview
7.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.10.4 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.10.5 GLAXOSMITHKLINE Key News & Latest Developments
7.11 ABBVIE
7.11.1 ABBVIE Company Summary
7.11.2 ABBVIE Business Overview
7.11.3 ABBVIE Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.11.4 ABBVIE Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.11.5 ABBVIE Key News & Latest Developments
7.12 ELI LILLY
7.12.1 ELI LILLY Company Summary
7.12.2 ELI LILLY Business Overview
7.12.3 ELI LILLY Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.12.4 ELI LILLY Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.12.5 ELI LILLY Key News & Latest Developments
7.13 BOEHRINGER SOHN
7.13.1 BOEHRINGER SOHN Company Summary
7.13.2 BOEHRINGER SOHN Business Overview
7.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.13.4 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.13.5 BOEHRINGER SOHN Key News & Latest Developments
7.14 AMGEN
7.14.1 AMGEN Company Summary
7.14.2 AMGEN Business Overview
7.14.3 AMGEN Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.14.4 AMGEN Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.14.5 AMGEN Key News & Latest Developments
7.15 GILEAD SCIENCES
7.15.1 GILEAD SCIENCES Company Summary
7.15.2 GILEAD SCIENCES Business Overview
7.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.15.4 GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.15.5 GILEAD SCIENCES Key News & Latest Developments
7.16 TAKEDA PHARMACEUTICAL
7.16.1 TAKEDA PHARMACEUTICAL Company Summary
7.16.2 TAKEDA PHARMACEUTICAL Business Overview
7.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.16.4 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.16.5 TAKEDA PHARMACEUTICAL Key News & Latest Developments
7.17 NOVO NORDISK
7.17.1 NOVO NORDISK Company Summary
7.17.2 NOVO NORDISK Business Overview
7.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.17.4 NOVO NORDISK Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.17.5 NOVO NORDISK Key News & Latest Developments
7.18 BIOGEN
7.18.1 BIOGEN Company Summary
7.18.2 BIOGEN Business Overview
7.18.3 BIOGEN Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.18.4 BIOGEN Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.18.5 BIOGEN Key News & Latest Developments
7.19 ABBOTT
7.19.1 ABBOTT Company Summary
7.19.2 ABBOTT Business Overview
7.19.3 ABBOTT Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.19.4 ABBOTT Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.19.5 ABBOTT Key News & Latest Developments
7.20 ASTELLAS PHARMA
7.20.1 ASTELLAS PHARMA Company Summary
7.20.2 ASTELLAS PHARMA Business Overview
7.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.20.4 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.20.5 ASTELLAS PHARMA Key News & Latest Developments
7.21 TEVA PHARMACEUTICAL INDUSTRIES
7.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Summary
7.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview
7.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.21.4 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.21.5 TEVA PHARMACEUTICAL INDUSTRIES Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pharmaceuticals and Biotechnology R & D Market Opportunities & Trends in Global Market
Table 2. Pharmaceuticals and Biotechnology R & D Market Drivers in Global Market
Table 3. Pharmaceuticals and Biotechnology R & D Market Restraints in Global Market
Table 4. Key Players of Pharmaceuticals and Biotechnology R & D in Global Market
Table 5. Top Pharmaceuticals and Biotechnology R & D Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharmaceuticals and Biotechnology R & D Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharmaceuticals and Biotechnology R & D Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharmaceuticals and Biotechnology R & D Product Type
Table 9. List of Global Tier 1 Pharmaceuticals and Biotechnology R & D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R & D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 30. ROCHE Company Summary
Table 31. ROCHE Pharmaceuticals and Biotechnology R & D Product Offerings
Table 32. ROCHE Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 33. ROCHE Key News & Latest Developments
Table 34. JOHNSON & JOHNSON Company Summary
Table 35. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Product Offerings
Table 36. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 37. JOHNSON & JOHNSON Key News & Latest Developments
Table 38. MERCK Company Summary
Table 39. MERCK Pharmaceuticals and Biotechnology R & D Product Offerings
Table 40. MERCK Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 41. MERCK Key News & Latest Developments
Table 42. NOVARTIS Company Summary
Table 43. NOVARTIS Pharmaceuticals and Biotechnology R & D Product Offerings
Table 44. NOVARTIS Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 45. NOVARTIS Key News & Latest Developments
Table 46. PFIZER Company Summary
Table 47. PFIZER Pharmaceuticals and Biotechnology R & D Product Offerings
Table 48. PFIZER Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 49. PFIZER Key News & Latest Developments
Table 50. SANOFI Company Summary
Table 51. SANOFI Pharmaceuticals and Biotechnology R & D Product Offerings
Table 52. SANOFI Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 53. SANOFI Key News & Latest Developments
Table 54. BAYER Company Summary
Table 55. BAYER Pharmaceuticals and Biotechnology R & D Product Offerings
Table 56. BAYER Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 57. BAYER Key News & Latest Developments
Table 58. BRISTOL-MYERS SQUIBB Company Summary
Table 59. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Product Offerings
Table 60. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 61. BRISTOL-MYERS SQUIBB Key News & Latest Developments
Table 62. ASTRAZENECA Company Summary
Table 63. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Product Offerings
Table 64. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 65. ASTRAZENECA Key News & Latest Developments
Table 66. GLAXOSMITHKLINE Company Summary
Table 67. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Product Offerings
Table 68. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 69. GLAXOSMITHKLINE Key News & Latest Developments
Table 70. ABBVIE Company Summary
Table 71. ABBVIE Pharmaceuticals and Biotechnology R & D Product Offerings
Table 72. ABBVIE Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 73. ABBVIE Key News & Latest Developments
Table 74. ELI LILLY Company Summary
Table 75. ELI LILLY Pharmaceuticals and Biotechnology R & D Product Offerings
Table 76. ELI LILLY Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 77. ELI LILLY Key News & Latest Developments
Table 78. BOEHRINGER SOHN Company Summary
Table 79. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Product Offerings
Table 80. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 81. BOEHRINGER SOHN Key News & Latest Developments
Table 82. AMGEN Company Summary
Table 83. AMGEN Pharmaceuticals and Biotechnology R & D Product Offerings
Table 84. AMGEN Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 85. AMGEN Key News & Latest Developments
Table 86. GILEAD SCIENCES Company Summary
Table 87. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Product Offerings
Table 88. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 89. GILEAD SCIENCES Key News & Latest Developments
Table 90. TAKEDA PHARMACEUTICAL Company Summary
Table 91. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Product Offerings
Table 92. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 93. TAKEDA PHARMACEUTICAL Key News & Latest Developments
Table 94. NOVO NORDISK Company Summary
Table 95. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Product Offerings
Table 96. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 97. NOVO NORDISK Key News & Latest Developments
Table 98. BIOGEN Company Summary
Table 99. BIOGEN Pharmaceuticals and Biotechnology R & D Product Offerings
Table 100. BIOGEN Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 101. BIOGEN Key News & Latest Developments
Table 102. ABBOTT Company Summary
Table 103. ABBOTT Pharmaceuticals and Biotechnology R & D Product Offerings
Table 104. ABBOTT Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 105. ABBOTT Key News & Latest Developments
Table 106. ASTELLAS PHARMA Company Summary
Table 107. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Product Offerings
Table 108. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 109. ASTELLAS PHARMA Key News & Latest Developments
Table 110. TEVA PHARMACEUTICAL INDUSTRIES Company Summary
Table 111. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Product Offerings
Table 112. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 113. TEVA PHARMACEUTICAL INDUSTRIES Key News & Latest Developments
List of Figures
Figure 1. Pharmaceuticals and Biotechnology R & D Segment by Type in 2022
Figure 2. Pharmaceuticals and Biotechnology R & D Segment by Application in 2022
Figure 3. Global Pharmaceuticals and Biotechnology R & D Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharmaceuticals and Biotechnology R & D Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceuticals and Biotechnology R & D Revenue in 2022
Figure 8. By Type - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 16. US Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 20. Germany Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 21. France Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 28. China Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 32. India Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 34. Brazil Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 37. Turkey Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 41. ROCHE Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. MERCK Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. NOVARTIS Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PFIZER Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. SANOFI Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BAYER Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. ABBVIE Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. ELI LILLY Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. AMGEN Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. BIOGEN Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. ABBOTT Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
